Effect of Treatment with Cyanidin-3-O-β-D-Glucoside on Rat Ischemic/Reperfusion Brain Damage

The Biology and Therapeutic Potential of the DDAH/ADMA Pathway

(2011) F. Arrigoni et al.   CURRENT PHARMACEUTICAL DESIGN

Neuroprotective effect of cyanidin-3-O-glucoside anthocyanin in mice with focal cerebral ischemia

(2011) Jiangyong Min et al.   NEUROSCIENCE LETTERS

Neuroprotective effect of silibinin in diabetic mice

(2011) Giuseppina Marrazzo et al.   NEUROSCIENCE LETTERS

Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke

(2010) Yasuhiro Nishiyama et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cellular ADMA: Regulation and action

(2009) Tom Teerlink et al.   PHARMACOLOGICAL RESEARCH

Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke

(2009) Frank Leypoldt et al.   PLoS One

Structure−Activity Relationships of Methoxychalcones as Inducers of Heme Oxygenase-1

(2008) Philip Sawle et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Inducers of Heme Oxygenase-1

(2008) M. Ferrandiz et al.   CURRENT PHARMACEUTICAL DESIGN

Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

(2008) Antonio Cuadrado et al.   CURRENT PHARMACEUTICAL DESIGN

Protective effect of the green tea component, l-theanine on environmental toxins-induced neuronal cell death

(2008) Hong-Suk Cho et al.   NEUROTOXICOLOGY

Pharmacological and Clinical Aspects of Heme Oxygenase

(2008) N. G. Abraham et al.   PHARMACOLOGICAL REVIEWS

Natural heme oxygenase-1 inducers in hepatobiliary function

(2008) Giovanni Li Volti et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Overexpression of Dimethylarginine Dimethylaminohydrolase Inhibits Asymmetric Dimethylarginine–Induced Endothelial Dysfunction in the Cerebral Circulation

(2007) Hayan Dayoub et al.   STROKE